Comparative bioinformatics analysis of the Wnt pathway in breast cancer: Selection of novel biomarker panels associated with ER status
- Klaudia Waszczykowska 1, Damian Kołat 1,2, Żaneta Kałuzińska-Kołat 1,2
- 1Department of Functional Genomics, Medical University of Lodz, Zeligowskiego 7/9, 90-752, Lodz, Poland.
- 2Department of Biomedicine and Experimental Surgery, Medical University of Lodz, Narutowicza 60, 90-136, Lodz, Poland.
- 0Department of Functional Genomics, Medical University of Lodz, Zeligowskiego 7/9, 90-752, Lodz, Poland.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.This study identifies novel Wnt-associated gene panels for breast cancer (BC) diagnosis and prognosis. These biomarkers can help classify BC subtypes and improve patient outcomes.
Area Of Science
- Oncology
- Genomics
- Bioinformatics
Background
- Breast cancer (BC) is a leading cause of cancer death globally, necessitating improved diagnostic and prognostic tools.
- The Wnt signaling pathway is implicated in BC progression, affecting cell cycle regulation and stem cell renewal.
- Identifying novel biomarkers is crucial for early BC classification and enhanced patient outcomes.
Purpose Of The Study
- To identify novel Wnt-associated biomarker panels for breast cancer (BC) patients.
- To develop molecular signatures for BC subtype classification and survival prediction.
- To leverage bioinformatic analyses for discovering diagnostic and prognostic markers.
Main Methods
- Weighted gene co-expression network analysis (WGCNA)
- Differential gene expression analysis
- Kaplan-Meier survival analysis, logistic regression, and receiver operating characteristic (ROC) curve construction using The Cancer Genome Atlas (TCGA) data.
Main Results
- Four distinct gene signatures were developed.
- Two signatures differentiate ER+ from ER-BC: TTC8, SLC5A7, PLCH1 (overall survival - OS); ZNF695, SLC7A5, PLCH1 (disease-free survival - DFS).
- Two signatures distinguish tumor from normal samples: SPC25, ANLN, KPNA2, SLC7A5 (OS); SPC25, KIF20A, SKA3, DTL, CDCA3, ANLN, TTK, RAD54L, MYBL2, ZNF695, SLC7A5 (DFS).
Conclusions
- The identified gene signatures show potential as diagnostic and prognostic tools for breast cancer.
- These Wnt-associated biomarkers could aid in classifying BC subtypes and predicting patient survival.
- Comprehensive bioinformatic analysis of TCGA data provides a foundation for novel BC biomarker discovery.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
02:54
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
01:41
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...

